CytoDyn Inc.

CytoDyn Inc.
Stock Exchange Other OTC
EPS
$0.21
Market Cap
$167.64 M
Shares Outstanding
364.43 M
Public Float
254.81 M

Profile

Address
1111 Main Street
Vancouver Washington 98660
United States
Employees -
Website http://www.cytodyn.com
Updated 07/08/2019
CytoDyn, Inc. is a clinical-stage biotechnology company, which engages in the clinical development and potential commercialization of humanized monoclonal antibodies for the treatment and prevention of human immunodeficiency virus infection. Its product pipeline includes PRO 140, CytoFeline, and Cytolin. The company was founded by Allen D.

Financials

View All

Anthony D. Caracciolo
Non-Executive Chairman
Nader Z. Pourhassan
President, Chief Executive Officer & Director